A review of the clinical pharmacology of methamphetamine.

@article{Cruickshank2009ARO,
  title={A review of the clinical pharmacology of methamphetamine.},
  author={Chris Cruickshank and Kyle R. Dyer},
  journal={Addiction},
  year={2009},
  volume={104 7},
  pages={
          1085-99
        }
}
AIMS To examine the literature regarding clinical pharmacokinetics, direct effects and adverse clinical outcomes associated with methamphetamine use. METHODS Relevant literature was identified through a PubMed search. Additional literature was obtained from relevant books and monographs. FINDINGS AND CONCLUSIONS The mean elimination half-life for methamphetamine is approximately 10 hours, with considerable inter-individual variability in pharmacokinetics. Direct effects at low-to-moderate… 

Tables from this paper

A review of basic to clinical studies of the association between hyperammonemia, methamphetamine.

TLDR
It seems that mental status changes in METH abusers may be related to ammonia intoxication or HAM; therefore, it is important to assess the serum level of ammonia in Meth intoxicated patients and resolve it.

eview ethamphetamine : An update on epidemiology , pharmacology , linical phenomenology , and treatment literature

TLDR
This review provides a broad-based update of the available literature covering methamphetamine research over the past two decades and concludes with recommendations for future research into methamphetamine addiction.

Pediatric Methamphetamine Toxicity: Clinical Manifestations and Therapeutic Use of Antipsychotics-One Institution's Experience.

TLDR
Pediatric patients with methamphetamine toxicity commonly manifest sympathomimetic signs and abnormal motor activity and neurologic manifestations unique to pediatric patients that will assist in making the correct diagnosis in cases of suspected methamphetamine toxicity are highlighted.

Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups

TLDR
Overall, end-of-treatment abstinence, reduced METH use or lower relapse rates were seen on METH dependent subgroups or attained significance only following post hoc analysis, irrespective of the medication tested.

Update on methamphetamine: an old problem that we have recently encountered

TLDR
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) considers the harm to public health caused by methamphetamine to be significant, even at low prevalence rates, due to its severe negative effects.

Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.

TLDR
The ability of varenicline to attenuate the positive subjective effects of methamphetamine in the laboratory suggests that varenICline should continue to be explored as a treatment for methamphetamine dependence.

Forensic Toxicology of Stimulants and Psychotropic Drugs

TLDR
Psychotropic drugs that have high lethality associated with overdose include typical antipsychotics, tricyclic antidepressants, and barbiturates, and non-benzodiazepines, which are associated with a risk for overdose, increased suicide rates, and onset of discontinuation syndrome.

Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors

TLDR
A comprehensive description of pertinent findings from human and animal studies is provided, with an emphasis on the current understanding of the underlying mechanisms of MA neuropsychotoxicity and its relevance to Parkinson’s disease or schizophrenia.
...

References

SHOWING 1-10 OF 191 REFERENCES

Methamphetamine and cardiovascular pathology: a review of the evidence.

TLDR
There is sufficient clinical and experimental evidence to suggest that methamphetamine can have adverse and potentially fatal effects on the cardiovascular system.

Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis

TLDR
A meta-analysis of the neuropsychological effects of MA abuse/dependence revealed broadly medium effect sizes, showing deficits in episodic memory, executive functions, information processing speed, motor skills, language, and visuoconstructional abilities.

Implications of chronic methamphetamine use: a literature review.

TLDR
Development of pharmacological interventions to improve cognitive impairments in chronic MA users may significantly improve the degree to which they may be able to participate in treatment, andtypical antipsychotics may have some promise in this regard.

Clinical Features of Sensitization to Methamphetamine Observed in Patients with Methamphetamine Dependence and Psychosis

TLDR
Molecular findings using animal sensitization models indicate that the phenomenon of sensitization to METH develops during abuse and plays a key role in the susceptibility to and onset of psychosis and in the refractory process.

A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline

Do Preclinical Findings of Methamphetamine-Induced Motor Abnormalities Translate to an Observable Clinical Phenotype?

TLDR
This review attempts to draw parallels between the animal and human changes in basal ganglia neurochemistry associated with MA exposure and offers explanations for why a parkinsonian phenotype is not apparent among individuals who use and abuse MA.

Acute Physiological and Behavioral Effects of Intranasal Methamphetamine in Humans

TLDR
Results show that intranasal methamphetamine produced predictable effects on multiple behavioral and physiological measures before peak plasma levels were observed, which might have important implications for potential toxicity after repeated doses.

Clinical effects of daily methamphetamine administration.

TLDR
The findings indicate that the disposition of methamphetamine and its subjective effects were not altered by this period of daily exposure to a low dose of the drug, and tolerance to the heart-rate accelerating effect was observed.

Effects of repeated oral methamphetamine administration in humans

TLDR
The pattern of methamphetamine's positive subjective effects were altered with chronic administration such that tolerance, or a decreased effect, occurred after repeated administration, and methamphetamine's negative subjective effects increased over days.

Corticolimbic dysregulation and chronic methamphetamine abuse.

TLDR
Cognitive deficits in abstinent methamphetamine abusers can affect a wide range of functions that can be important for success in maintaining drug abstinence, and potential therapies may combine behavioral approaches with medications that can improve cognitive control.
...